Literature DB >> 20573704

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons.

Chee Yeun Chung1, Pawel Licznerski, Kambiz N Alavian, Antonio Simeone, Zhicheng Lin, Eden Martin, Jeffery Vance, Ole Isacson.   

Abstract

Two adjacent groups of midbrain dopaminergic neurons, A9 (substantia nigra pars compacta) and A10 (ventral tegmental area), have distinct projections and exhibit differential vulnerability in Parkinson's disease. Little is known about transcription factors that influence midbrain dopaminergic subgroup phenotypes or their potential role in disease. Here, we demonstrate elevated expression of the transcription factor orthodenticle homeobox 2 in A10 dopaminergic neurons of embryonic and adult mouse, primate and human midbrain. Overexpression of orthodenticle homeobox 2 using lentivirus increased levels of known A10 elevated genes, including neuropilin 1, neuropilin 2, slit2 and adenylyl cyclase-activating peptide in both MN9D cells and ventral mesencephalic cultures, whereas knockdown of endogenous orthodenticle homeobox 2 levels via short hairpin RNA reduced expression of these genes in ventral mesencephalic cultures. Lack of orthodenticle homeobox 2 in the ventral mesencephalon of orthodenticle homeobox 2 conditional knockout mice caused a reduction of midbrain dopaminergic neurons and selective loss of A10 dopaminergic projections. Orthodenticle homeobox 2 overexpression protected dopaminergic neurons in ventral mesencephalic cultures from Parkinson's disease-relevant toxin, 1-methyl-4-phenylpyridinium, whereas downregulation of orthodenticle homeobox 2 using short hairpin RNA increased their susceptibility. These results show that orthodenticle homeobox 2 is important for establishing subgroup phenotypes of post-mitotic midbrain dopaminergic neurons and may alter neuronal vulnerability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573704      PMCID: PMC2892944          DOI: 10.1093/brain/awq142

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

Authors:  D Vaudry; B J Gonzalez; M Basille; L Yon; A Fournier; H Vaudry
Journal:  Pharmacol Rev       Date:  2000-06       Impact factor: 25.468

3.  Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.

Authors:  Lavinia Albéri; Paola Sgadò; Horst H Simon
Journal:  Development       Date:  2004-06-02       Impact factor: 6.868

4.  Differentiation of the midbrain dopaminergic pathways during mouse development.

Authors:  Zhaoliang Hu; Margaret Cooper; David P Crockett; Renping Zhou
Journal:  J Comp Neurol       Date:  2004-08-23       Impact factor: 3.215

5.  Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo.

Authors:  Tanjew Dittgen; Axel Nimmerjahn; Shoji Komai; Pawel Licznerski; Jack Waters; Troy W Margrie; Fritjof Helmchen; Winfried Denk; Michael Brecht; Pavel Osten
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

6.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

Review 7.  Development of dopaminergic neurons in the mammalian brain.

Authors:  N Prakash; W Wurst
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

8.  Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Authors:  Dóra Reglodi; Andrea Lubics; Andrea Tamás; Luca Szalontay; István Lengvári
Journal:  Behav Brain Res       Date:  2004-05-05       Impact factor: 3.332

9.  Otx2 regulates subtype specification and neurogenesis in the midbrain.

Authors:  Bertrand Vernay; Muriel Koch; Flora Vaccarino; James Briscoe; Antonio Simeone; Ryoichiro Kageyama; Siew-Lan Ang
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

10.  Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain.

Authors:  Eduardo Puelles; Alessandro Annino; Francesca Tuorto; Alessandro Usiello; Dario Acampora; Thomas Czerny; Claude Brodski; Siew-Lan Ang; Wolfgang Wurst; Antonio Simeone
Journal:  Development       Date:  2004-05       Impact factor: 6.868

View more
  26 in total

1.  Midbrain dopamine neurons associated with reward processing innervate the neurogenic subventricular zone.

Authors:  Jessica B Lennington; Sara Pope; Anna E Goodheart; Linda Drozdowicz; Stephen B Daniels; John D Salamone; Joanne C Conover
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

2.  RNA Isolation from Cell Specific Subpopulations Using Laser-capture Microdissection Combined with Rapid Immunolabeling.

Authors:  Audrey Chabrat; Hélène Doucet-Beaupré; Martin Lévesque
Journal:  J Vis Exp       Date:  2015-04-11       Impact factor: 1.355

3.  Lysosomes to combat Parkinson's disease.

Authors:  Ole Isacson
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

4.  Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.

Authors:  Jean-Francois Poulin; Jian Zou; Janelle Drouin-Ouellet; Kwang-Youn A Kim; Francesca Cicchetti; Rajeshwar B Awatramani
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

5.  Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression.

Authors:  Meige Zheng; Luyan Jiao; Xiaolu Tang; Xianhong Xiang; Xiaomei Wan; Yan Yan; Xingjian Li; Guofeng Zhang; Yonglin Li; Bin Jiang; Huaibin Cai; Xian Lin
Journal:  FASEB J       Date:  2017-04-19       Impact factor: 5.191

Review 6.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

7.  Isolation, culture and long-term maintenance of primary mesencephalic dopaminergic neurons from embryonic rodent brains.

Authors:  Maria Weinert; Tharakeswari Selvakumar; Travis S Tierney; Kambiz N Alavian
Journal:  J Vis Exp       Date:  2015-02-19       Impact factor: 1.355

8.  Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration.

Authors:  Artem Kaplan; Krista J Spiller; Christopher Towne; Kevin C Kanning; Ginn T Choe; Adam Geber; Turgay Akay; Patrick Aebischer; Christopher E Henderson
Journal:  Neuron       Date:  2014-01-22       Impact factor: 17.173

9.  Tau Deficiency Down-Regulated Transcription Factor Orthodenticle Homeobox 2 Expression in the Dopaminergic Neurons in Ventral Tegmental Area and Caused No Obvious Motor Deficits in Mice.

Authors:  Xiaolu Tang; Luyan Jiao; Meige Zheng; Yan Yan; Qi Nie; Ting Wu; Xiaomei Wan; Guofeng Zhang; Yonglin Li; Song Wu; Bin Jiang; Huaibin Cai; Pingyi Xu; Jinhai Duan; Xian Lin
Journal:  Neuroscience       Date:  2018-01-11       Impact factor: 3.590

Review 10.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.